We could not find any results for:
Make sure your spelling is correct or try broadening your search.
We recently downgraded Auxilium Pharmaceuticals, Inc. (AUXL) to Underperform with a price target of $17.00. Auxilium Pharma’s third quarter results were disappointing with the company...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0.0089 | 41.5887850467 | 0.0214 | 0.0303 | 0.0214 | 3250 | 0.02208462 | CS |
26 | -0.0251 | -45.3068592058 | 0.0554 | 0.0554 | 0.0214 | 1114 | 0.02750641 | CS |
52 | -0.0003 | -0.980392156863 | 0.0306 | 0.0554 | 0.0214 | 780 | 0.02750641 | CS |
156 | -0.0297 | -49.5 | 0.06 | 0.081 | 0.0214 | 2990 | 0.04755319 | CS |
260 | -0.0847 | -73.652173913 | 0.115 | 0.205 | 0.0214 | 5259 | 0.10005587 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions